AI Article Synopsis

  • Pneumococcal diseases lead to high rates of illness and death, especially in developing regions like the Asia-Pacific, where vaccination rates among adults are low.
  • The literature review summarized the disease’s impact and vaccination efforts in specific Asia-Pacific countries by analyzing published studies from 2010 to 2020.
  • Findings show that the burden of pneumococcal disease varies among adult populations, highlighting the need for more research and stronger vaccination programs in areas lacking them.

Article Abstract

Introduction: Pneumococcal diseases are common and cause significant morbidity and mortality, with higher rates especially in developing areas including many in the Asia-Pacific (AP) region. However, current strategies to prevent pneumococcal disease in adults are quite complicated and not well implemented among many AP areas, and vaccination coverage rates among adults are generally low or perceived as low in the region. Thus, this literature review's purpose was to summarize the disease burden and vaccination against pneumococcal diseases among adults in select AP areas (Australia, Hong Kong, India, Indonesia, South Korea, Malaysia, New Zealand, the Philippines, Singapore, Taiwan, Thailand, and Vietnam).

Areas Covered: This systematic review included published articles from January 2010 to August 2020 using MEDLINE/Embase. Grey literature websites were searched for national immunization programs and medical society vaccination recommendations from areas of interest. A total of 69 publications were identified.

Expert Opinion: In the AP region, pneumococcal disease burden and serotype prevalence are variable among adult populations, particularly among older adults. Data was provided primarily from countries with established national immunization programs (NIPs). Further research on the disease burden and emphasis on the benefits of vaccination in AP areas lacking pneumococcal vaccination programs is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14760584.2022.2016399DOI Listing

Publication Analysis

Top Keywords

disease burden
16
pneumococcal disease
12
burden vaccination
8
vaccination pneumococcal
8
disease adults
8
adults select
8
pneumococcal diseases
8
national immunization
8
immunization programs
8
disease
6

Similar Publications

Objective: The purpose of study was to explore family caregiver perspectives on work-life balance while caring for adults with Parkinson's Disease.

Methods: The study was performed using a convergent mixed methods design and a revised adaptation of the Work-Life Conflict model. Caregivers completed surveys followed by semi-structured interviews (N = 40).

View Article and Find Full Text PDF

Pathways to Racial/Ethnic Inequalities in Dementia.

Annu Rev Clin Psychol

January 2025

1Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA; email:

Individuals from minoritized racial/ethnic groups face a disproportionate burden of Alzheimer's disease and related dementias. This health inequality reflects structural racism, which creates and sustains racial differences in social determinants of health, including education access and quality, economic stability, social and community context, neighborhood and built environment, and health care access and quality. Thus, understanding pathways that lead to dementia inequalities requires addressing individual- and system-level factors.

View Article and Find Full Text PDF

Background: The determinants of differences in host infectivity among Cryptosporidium species and subtypes are poorly understood. Results from recent comparative genomic studies suggest that gains and losses of multicopy subtelomeric genes encoding insulinase-like proteases (INS-19 and INS-20 in Cryptosporidium parvum and their orthologs in closely related species) may potentially contribute to these differences.

Methodology/principal Findings: In this study, we investigated the expression and biological function of the INS-19 and INS-20 of C.

View Article and Find Full Text PDF

Introduction: Visceral leishmaniasis (VL) also known as Kala-azar is one of the neglected tropical diseases (NTD) of public health importance. Despite being a disease of a long history, the condition remains poorly studied especially in East Africa. For instance, whereas, the geographical location of the disease is known, there is a stark paucity of data on the burden, risk factors and clinical outcomes of this contribution in Northeastern Uganda.

View Article and Find Full Text PDF

Chikungunya virus (CHIKV) is an arthritogenic alphavirus that has re-emerged to cause large outbreaks of human infections worldwide. There are currently no approved antivirals for treatment of CHIKV infection. Recently, we reported that the ribonucleoside analog 4'-fluorouridine (4'-FlU) is a highly potent inhibitor of CHIKV replication, and targets the viral nsP4 RNA dependent RNA polymerase.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!